DBIA
AMGN icon

Dumont & Blake Investment Advisors’s Amgen AMGN Stock Holding History

Dumont & Blake Investment Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$19K – 180
2019
Q1 		$19K Buy
+100
New +$19.1K 0.01% 173

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dumont & Blake Investment Advisors's AMGN Position: Q1 2026 in Review

Dumont & Blake Investment Advisors reduced its Amgen (AMGN) stake by 2.3% in Q1 2026, selling an estimated $73.1K and leaving 8,666 shares worth $3.05M. The position accounts for 0.76% of the portfolio, ranked #29.

Dumont & Blake Investment Advisors first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.6M in Q2 2024. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Dumont & Blake Investment Advisors held 8,666 shares of Amgen worth $3.05M as of Q1 2026.
  • Dumont & Blake Investment Advisors sold 205 Amgen shares in Q1 2026, an estimated $73.1K.
  • Amgen made up 0.76% of Dumont & Blake Investment Advisors's portfolio in Q1 2026, its #29 holding.
  • Dumont & Blake Investment Advisors first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Dumont & Blake Investment Advisors's Amgen position peaked at $5.6M in Q2 2024.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Dumont & Blake Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.